FDA Approved: FONDAPARINUX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental ANDA for Fondaparinux sodium from Dr. Reddy's Laboratories Limited, authorizing the generic product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Fondaparinux sodium (Fondaparinux sodium)

Snippet

SUPPL AP for FONDAPARINUX SODIUM (FONDAPARINUX SODIUM)